The FDA has named George Tidmarsh, a seasoned biotech executive and physician-scientist with a background in oncology and pediatrics, as Director of the Center for Drug Evaluation and Research (CDER). Tidmarsh's extensive experience in drug development and leadership roles in companies such as La Jolla Pharmaceutical and Horizon Pharma is expected to bring scientific, regulatory, and operational expertise to the agency. FDA Commissioner Marty Makary praised Tidmarsh's comprehensive drug development background spanning bench to bedside. This leadership change signals a strategic focus on advancing innovative therapeutics review at the FDA.